Skip to search formSkip to main contentSkip to account menu

azidopine

Known as: 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-(trifluoromethyl)phenyl)-, 2-((4-azidobenzoyl)amino)ethyl ethyl ester 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Treatment of cancer with chemotherapy often faces drug resistance issues, which can stop after a period of remission. This… 
2012
2012
RésuméLa MDR « Multidrug resistance » est un obstacle majeur au traitement clinique des cancers par chimiothérapie. Cette… 
2007
2007
We have performed isobologram analyses of the ability of tamoxifen (TAM) to alter the response to Adriamycin (ADR) and… 
2006
2006
2006
Structural features of the multidrug resistance protein encoded by the mouse mdrl gene were studied in multidrug-resistant cell… 
2004
2004
In the clinic, drug resistant develops in patients previously treated not only with chemotherapy, but also after radiotherapy. We… 
1999
1999
Previously, a series of 21 N10-substituted phenoxazines were examined for reversing vinca alkaloid resistance against MDR KBChR-8…